Journal of Cystic Fibrosis
60 papers1 directions
The Journal of Cystic Fibrosis is a specialized publication focusing on the clinical, social, and basic science aspects of cystic fibrosis. Active from 2005 to 2025, the venue serves as a repository for research concerning airway infections, epidemiological trends, and the efficacy of therapeutic interventions. Its corpus includes studies on the evolution of transcriptional regulators in pathogens such as M. abscessus and the longitudinal impact of infection prevention and control guidelines.
In the context of machine learning and data science, the journal provides a platform for applying computational models to complex biological and clinical datasets. Research published here often utilizes data-driven approaches to analyze within-host evolution, selection scans for genetic drivers of bacterial survival, and the development of non-invasive diagnostic technologies such as resonant acoustic rheometry. These studies bridge the gap between technical methodology and practical applications in chronic disease management, particularly regarding the analysis of treatment-emergent organisms and the outcomes of modulator therapies.
The venue features contributions from prolific researchers in the field, including Jochen G. Mainz, Marianne S. Muhlebach, and B. Wiedemann. By hosting investigations into the association between antibiotic use and pathogenic adaptation, the journal facilitates the integration of quantitative analysis into cystic fibrosis care. It functions as a specialized venue for researchers applying analytical tools to improve patient monitoring, diagnostic accuracy, and long-term therapeutic strategies.
Papers by Year
Top Research Directions
Research directions most represented by papers from this venue.
Top Authors
Impactful Papers
Papers from this venue that shaped research clusters.
Foundational
Related Venues
Venues with the most similar research cluster distributions.
Papers
| Title | Year |
|---|
| 16 Artificial intelligence integrating gut microbiome multi-omics to predict clinical outcomes in children with cystic fibrosis | 2025 |
| 196 Development of a rapid, non-invasive in situ detection of in vitro mucus characteristics using resonant acoustic rheometry (RAR) | 2025 |
| 283 Hierarchical protein unfolding at the site of a functional conformational change in human CFTR is the Achilles’ Heel controlling biogenesis efficiency and corrector-drug mechanism | 2025 |
| 73 Epidemiology of Pseudomonas aeruginosa infection before and after the 2013 Infection Prevention and Control Guidelines | 2025 |
| 79 Selection scan reveals algG as a putative driver of Pseudomonas aeruginosa survival in the post-ETI lung | 2025 |
| 853 Establishing a satellite cystic fibrosis clinic: one center’s experience | 2025 |
| 89 Within-host evolution of transcriptional regulators drives pathogenic adaptation in M. abscessus | 2025 |
| AI-facilitated home monitoring for cystic fibrosis exacerbations across pediatric and adult populations | 2025 |
| Association between inhaled antibiotic use and treatment-emergent organisms among Canadian people with cystic fibrosis | 2025 |
| P182 Physiotherapy discontinuation in adult patients on highly effective modulator therapy | 2025 |
| P364 Emergent airway infections with chronic inhaled antibiotics | 2025 |
| 514 Real-word effectiveness of a Pseudomonas aeruginosa eradication protocol in children with cystic fibrosis | 2024 |
| 836 Aggregated genetic modifiers predict lung function in childrenwith CF aged 5 to 6 | 2024 |
| Changes in factors associated with inhaled antibiotic prescriptions for people with cystic fibrosis over time in the U.S. | 2024 |
| Vitamin D status and variable responses to supplements depend in part on genetic factors in adults with cystic fibrosis | 2024 |
| WS05.03 Pharmacological improvement of CFTR function rescues airway epithelial homeostasis and host defense in children with cystic fibrosis | 2024 |
| WS05.06 Integration of the LacZ and CFTR transgene using Find and cut-and-transfer (FiCAT) | 2024 |
| 335 Cryogenic electron microscopy studies of human CFTR folding and conformational dynamics elucidate a novel potentiator binding site in the nucleotide binding domains that supports an alternative ch | 2023 |
| Association of Pseudomonas aeruginosa incident infections with adherence to cystic fibrosis foundation care guidelines | 2023 |
| WS09.05 Aggregated genetic modifiers predict lung dysfunction at age 5–6 years in children with cystic fibrosis | 2023 |
| WS10.04 Analyzes of worldwide inhaled antibiotic prescriptions for Pseudomonas aeruginosa | 2023 |
| Predicting risk-adjusted incidence rates of methicillin-resistant Staphylococcus Aureus and Pseudomonas Aeruginosa in cystic fibrosis programs in the United States | 2022 |
| 568: Quantifying regional pulmonary ventilation changes pre-/postivacaftor treatment in same subject using hyperpolarized 3He MRI | 2021 |
| Barriers implementing infection prevention and control experienced by healthcare workers, people with CF and parents | 2021 |
| Longitudinal changes and regional variation of incident infection rates at cystic fibrosis centers, United States 2010-2016 | 2021 |
| Pregnancy in cystic fibrosis: Review of the literature and expert recommendations | 2021 |
| WS08.6 Impact of triple therapy on IVantibiotic requirements in cystic fibrosis: combining evidence from a patient Registry and randomised trials | 2021 |
| WS17.1 Enhancing site-specific gene integration efficiency for permanent CFTR gene correction | 2020 |
| P019 Advanced molecular dynamics simulations for understanding the functions and dysfunctions of the CFTR channel | 2018 |
| P220 Pharmacist consultation introduced to annual review of adults with cystic fibrosis | 2018 |
| 25 Unsolved severe chronic rhinosinusitis elucidated by extensive CFTR genotyping | 2017 |
| 387 Exploring outpatient clinic attendance in adults with CF: what influences attendance? | 2017 |
| Rare cases of Blastobotrys raffinosifermentans as cause of FEV1 decline in two CF patients – Whole genome sequencing to exclude transmission | 2017 |
| Use of hyperpolarized helium-3 MRI to assess response to ivacaftor treatment in patients with cystic fibrosis | 2017 |
| WS09.1 3D structures of the full length CFTR protein: combining theoretical and experimental data | 2017 |
| 82 The upper airway role in acquisition of Pseudomonas aeruginosa colonization in cystic fibrosis patients. Longitudinal single centre analysis following 153 CF patients for up to 10.6 years | 2016 |
| Sino nasal inhalation of isotonic versus hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis — Results of a multicenter, prospective, randomized, double-blind, controlled trial | 2016 |
| 146 Sinonasal inhalation of isotonic vs. hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis – results of a multicentre, double-blind, controlled prospective trial | 2015 |
| 300 Pseudomonas aeruginosa colonization in a CF child's upper and lower airways: a father's meticulous approach to successful eradication | 2014 |
| Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose tolerance | 2014 |
| Sinonasal inhalation of dornase alfa administered by vibrating aerosol to cystic fibrosis patients: A double-blind placebo-controlled cross-over trial | 2014 |
| WS23.1 Models of the 3D structure of CFTR: from the understanding of the protein functions to the design of correctors | 2014 |
| WS3.2 The effect of ivacaftor treatment on lung ventilation defects, as measured by hyperpolarized helium-3 MRI, on patients with cystic fibrosis and a G551D-CFTR mutation | 2014 |
| 178 Does nasal and bronchial nitric oxide in CF correlate to pathogen colonization in both airway levels? | 2013 |
| 183 Pseudomonas aeruginosa acquisition in CF patients in the context of otorhinolarynological surgery or dentist attendance – Case series and discussion of preventive concepts | 2013 |
| Cost effectiveness of newborn screening for cystic fibrosis: A simulation study | 2013 |
| WS4.1 New molecular models of CFTR based on ABC transporter structures | 2013 |
| 273 Smelling and tasting in CF patients compared to age matched healthy controls | 2012 |
| Effect of acute exacerbations on skeletal muscle strength and physical activity in cystic fibrosis | 2012 |
| 83* Sinonasal inhalation of tobramycin in cystic fibrosis patients with P. aeruginosa colonization of the upper airways – results of a multicentric placebo-controlled pilot study | 2011 |
Page 1/2 next »